Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:Partnership

Hi Ivebeenthere, could you be more specific please? I can't find anything anywhere. Who's the partnership with and for what? Thanks!  rate and reply

Partnership

https://opsensmedical.com/ Opsens is talking about it today but it is on the Vascular Perspective site since august 10th.Maybee Opsens has been accumulating good news to release them in salvo.  rate and reply

New Partnership Agreement

New agreement signed with Vascular Perspective. That thing is on sale take adventage of it ! GL  rate and reply

RE:RE:Reiterated

2 things: 1. Buy the rumour sell the news. 2. The market is bad overall 3. Rates up   rate and reply

RE:Reiterated

Would love to know what's been causing such a persistent sell off lately . We get FDA approval and we've been dropping ever since .   rate and reply

RE:RE:RE:Still buying

Good for you! I wish i had your insight.  rate and reply

RE:RE:Still buying

Happy to say, I have an average price under a buck. One of my better decisions, helping to offset some hmm less happy choices.... Largest holding.  rate and reply

Reiterated

Justin Keywood analyst at Stifel Nicolaus reiterated Opsens yesterday For what its worth today  rate and reply

RE:RE:RE:RE:Still buying

Its not ignored by me although not with great success. I bought 2400 shares at 2.69$. When you're a believer its hard to resist ! GL  rate and reply

RE:RE:RE:Still buying

Good news ,this morning about that first procedure in the U.S. being ignored in a fearful maket says "part of the happy  few"  rate and reply

RE:For French speaking followers...

Merci Bossu.  Au risque de me repeter : cette entreprise est un joyau! Je suis encore actionnaire et tres fiere de l'etre...    rate and reply

For French speaking followers...

OPSENS ANNONCE LA PREMIERE PROCEDURE AVEC LE SAVVYWIRE AUX ETATS-UNIS PAR LE DR PHILIPPE GENEREUX DU MORRISTOWN MEDICAL CENTER English ...read more

New Press Release - OPSENS ANNOUNCES FIRST SAVVYWIRE PROCEDURE IN THE UNITED STATES BY DR. PHILIPPE GENEREUX OF MORRISTOWN MEDICAL CENTER

QUEBEC CITY, Sept. 23, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that Dr. Philippe Genereux, Director of the...read article.

RE:RE:Still buying

To have an average price of 1.50$ youd have to have a position in january 2021 and to have a 1$ average price youd have to buy before november 2020.I'm not part of those happy few. I looked at the...read more

RE:Still buying

Wondering if anybody here has an average cost under a $1? $1.50?  rate and reply

Boston Conference

Does anybody think that what happened in Boston was: They presented their ground breaking device (FDA approved) Then the cardiologist went on and ate their free bacon then went home? Im convinced that...read more

RE:RE:Still buying

Ops is now on sale. People with budget should start buying it as sp is getting cheaper.  rate and reply

RE:Still buying

Agreed . I too added today .  rate and reply

Still buying

3$ is cheap 2.91 even better  rate and reply